264 related articles for article (PubMed ID: 10739663)
1. The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation.
Lemonnier J; Delannoy P; Hott M; Lomri A; Modrowski D; Marie PJ
Exp Cell Res; 2000 Apr; 256(1):158-67. PubMed ID: 10739663
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of protein kinase Calpha, interleukin-1alpha, and RhoA guanosine 5'-triphosphatase in osteoblasts expressing the Ser252Trp fibroblast growth factor 2 receptor Apert mutation: identification by analysis of complementary DNA microarray.
Lomri A; Lemonnier J; Delannoy P; Marie PJ
J Bone Miner Res; 2001 Apr; 16(4):705-12. PubMed ID: 11315998
[TBL] [Abstract][Full Text] [Related]
3. Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis.
Lemonnier J; Haÿ E; Delannoy P; Lomri A; Modrowski D; Caverzasio J; Marie PJ
J Bone Miner Res; 2001 May; 16(5):832-45. PubMed ID: 11341328
[TBL] [Abstract][Full Text] [Related]
4. Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome.
Lomri A; Lemonnier J; Hott M; de Parseval N; Lajeunie E; Munnich A; Renier D; Marie PJ
J Clin Invest; 1998 Mar; 101(6):1310-7. PubMed ID: 9502772
[TBL] [Abstract][Full Text] [Related]
5. Increased EFG- and PDGFalpha-receptor signaling by mutant FGF-receptor 2 contributes to osteoblast dysfunction in Apert craniosynostosis.
Miraoui H; Ringe J; Häupl T; Marie PJ
Hum Mol Genet; 2010 May; 19(9):1678-89. PubMed ID: 20124286
[TBL] [Abstract][Full Text] [Related]
6. Increased osteoblast apoptosis in apert craniosynostosis: role of protein kinase C and interleukin-1.
Lemonnier J; Haÿ E; Delannoy P; Fromigué O; Lomri A; Modrowski D; Marie PJ
Am J Pathol; 2001 May; 158(5):1833-42. PubMed ID: 11337381
[TBL] [Abstract][Full Text] [Related]
7. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
Mansukhani A; Bellosta P; Sahni M; Basilico C
J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
[TBL] [Abstract][Full Text] [Related]
8. A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis.
Chen L; Li D; Li C; Engel A; Deng CX
Bone; 2003 Aug; 33(2):169-78. PubMed ID: 14499350
[TBL] [Abstract][Full Text] [Related]
9. Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling.
Marie PJ; Debiais F; Haÿ E
Histol Histopathol; 2002; 17(3):877-85. PubMed ID: 12168799
[TBL] [Abstract][Full Text] [Related]
10. Apert syndrome mutant FGFR2 and its soluble form reciprocally alter osteogenesis of primary calvarial osteoblasts.
Suzuki H; Suda N; Shiga M; Kobayashi Y; Nakamura M; Iseki S; Moriyama K
J Cell Physiol; 2012 Sep; 227(9):3267-77. PubMed ID: 22105374
[TBL] [Abstract][Full Text] [Related]
11. A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome.
Tanimoto Y; Yokozeki M; Hiura K; Matsumoto K; Nakanishi H; Matsumoto T; Marie PJ; Moriyama K
J Biol Chem; 2004 Oct; 279(44):45926-34. PubMed ID: 15310757
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of sodium-dependent phosphate transport and signaling mechanisms induced by basic fibroblast growth factor in MC3T3-E1 osteoblast-like cells.
Suzuki A; Palmer G; Bonjour JP; Caverzasio J
J Bone Miner Res; 2000 Jan; 15(1):95-102. PubMed ID: 10646118
[TBL] [Abstract][Full Text] [Related]
13. A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis.
Yin L; Du X; Li C; Xu X; Chen Z; Su N; Zhao L; Qi H; Li F; Xue J; Yang J; Jin M; Deng C; Chen L
Bone; 2008 Apr; 42(4):631-43. PubMed ID: 18242159
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells.
Hurley MM; Tetradis S; Huang YF; Hock J; Kream BE; Raisz LG; Sabbieti MG
J Bone Miner Res; 1999 May; 14(5):776-83. PubMed ID: 10320526
[TBL] [Abstract][Full Text] [Related]
15. The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific.
Debiais F; Hott M; Graulet AM; Marie PJ
J Bone Miner Res; 1998 Apr; 13(4):645-54. PubMed ID: 9556064
[TBL] [Abstract][Full Text] [Related]
16. Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders.
Fragale A; Tartaglia M; Bernardini S; Di Stasi AM; Di Rocco C; Velardi F; Teti A; Battaglia PA; Migliaccio S
Am J Pathol; 1999 May; 154(5):1465-77. PubMed ID: 10329600
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor receptor 4 (FGFR4) expression in newborn murine calvaria and primary osteoblast cultures.
Cool S; Jackson R; Pincus P; Dickinson I; Nurcombe V
Int J Dev Biol; 2002; 46(4):519-23. PubMed ID: 12141439
[TBL] [Abstract][Full Text] [Related]
18. Activating (P253R, C278F) and dominant negative mutations of FGFR2: differential effects on calvarial bone cell proliferation, differentiation, and mineralization.
Ratisoontorn C; Fan GF; McEntee K; Nah HD
Connect Tissue Res; 2003; 44 Suppl 1():292-7. PubMed ID: 12952211
[TBL] [Abstract][Full Text] [Related]
19. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
[TBL] [Abstract][Full Text] [Related]
20. Regulation of fibroblast growth factor 2 and fibroblast growth factor receptors by transforming growth factor beta in human osteoblastic MG-63 cells.
Sobue T; Gravely T; Hand A; Min YK; Pilbeam C; Raisz LG; Zhang X; Larocca D; Florkiewicz R; Hurley MM
J Bone Miner Res; 2002 Mar; 17(3):502-12. PubMed ID: 11874241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
